Skip to main content

Table 1 Basic demographics, volumetric data and patient characteristics

From: Biventricular myocardial strain analysis in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC) using cardiovascular magnetic resonance feature tracking

 

Healthy volunteers

ARVC

Borderline ARVC

pos. family history

n

10

20

30

22

Sex (m/w)

5/5

17/3

19/11

16/6

Age

24.3 ± 3.0

50.7 ± 16.9*,#

41.4 ± 14.5*,#

29.3 ± 11.7

Weight (kg)

66.4 ± 9.4

81.3 ± 17.3

80.7 ± 16.7

80.3 ± 15.7

Height (cm)

176.1 ± 9.1

178.4 ± 8.0

175.6 ± 8.5

179.3 ± 9.0

Body surface area (m 2 )

1.81 ± 0.17

1.99 ± 0.22

1.96 ± 0.22

1.99 ± 0.22

RVEDVI (ml/m 2 )

88.1 ± 12.8

124.4 ± 40.4*,$,#

100.4 ± 31.9

93.2 ± 15.0

RVESVI (ml/m 2 )

36.7 ± 6.4

78.0 ± 39.8**,$,##

53.2 ± 25.0

45.7 ± 10.8

RVEF (%)

58.3 ± 4.8

40.4 ± 10.9**,$$,##

49.2 ± 8.4*

52.6 ± 6.9

LVEDVI (ml/m 2 )

79.0 ± 8.2

84.3 ± 18.8

89.4 ± 20.6

88.7 ± 13.2

LVESVI (ml/m 2 )

28.8 ± 4.5

33.5 ± 14.5

37.7 ± 13.3

35.4 ± 7.1

LVEF (%)

63.6 ± 4.2

60.7 ± 9.2

58.2 ± 7.1

61.3 ± 5.2

Task force score

0

5.5 ± 1.4

1.4 ± 0.8

1.5 ± 0.7

WMA (n)

10/0/0/0/0

7/0/1/4/8

23/0/0/4/3

20/0/0/0/2

RVEF > 45/45 > RVEF > 40/RVEF < 40

10/0/0

8/4/8

22/5/3

20/2/0

  1. Abbreviations: RVEDVI Right Ventricular End-diastolic Volume Index, RVESVI Right Ventricular End-systolic Volume Index, RVEF Right Ventricular Ejection Fraction, LVEDVI Left Ventricular End-diastolic Volume Index, LVESVI Left Ventricular End-systolic Volume Index, LVEF Left Ventricular Ejection Fraction WMA Wall Motion Abnormalities.
  2. WMA is graded in the following order: no WMA/Hypokinesia/Akinesia/Dyskinesia/ Aneurysm.
  3. * significant difference compared to healthy volunteers.
  4. $ significant difference compared to borderline ARVC patients.
  5. # significant difference compared to subjects with positive family history for ARVC.
  6. level of significance * p < 0.05; ** p < 0.01; $$ p < 0.01; ## p < 0.01.